Effects of withdrawal of antiparkinson medication on gait and clinical score in the Parkinson patient
Identifieur interne : 000364 ( Main/Corpus ); précédent : 000363; suivant : 000365Effects of withdrawal of antiparkinson medication on gait and clinical score in the Parkinson patient
Auteurs : S. W. Pederson ; T. Eriksson ; B. ÖbergSource :
- Acta Neurologica Scandinavica [ 0001-6314 ] ; 1991-07.
English descriptors
- KwdEn :
Abstract
ABSTRACT Objective testing of medication is needed in Parkinson's disease. Gait analysis and clinical evaluation were done before and after a 24‐h withdrawal of Parkinson medication. Twelve patients with stable, mild to moderate idiopathic parkinsonism (Hoehn and Yahr 1‐3; seven men and five women mean age 59.9 years, mean duration of disease 6 years) were tested with gait analysis walking in five different paces. Velocity of gait, stride length and stride frequency, as well as stride length at constant velocity were calculated. Regression coefficients for the relation between stride length and stride frequency were also calculated. Clinical scoring according to the Webster rating scale and Hoehn and Yahr were performed for each test. Clinical functional assessment with a specially designed rise and gait test, an arm cycle test and the wooden rods test were done. Evaluated clinical score increased significantly (p < 0.05) using both clinical tests. Maximum gait velocity (p < 0.01), stride length at max. velocity (p < 0.01), and stride length at constant velocity (p < 0.03) were significantly decreased without medication. Stride frequency did not change. In the functional assessment tests only performance on the arm cycle test (p < 0.03) was less well performed without medication. There was correlation between clinical score, gait and clinical functional assessment. The methods used detected significant changes in variables of gait as well as clinical scoring and some of the clinical functional assessments when medication was withdrawn for a 24‐h period. The methods were useful in evaluation of pharmacological treatment.
Url:
DOI: 10.1111/j.1600-0404.1991.tb04894.x
Links to Exploration step
ISTEX:E8FD9C2A334D90F3AFF97EF49B6BBA0430CA8B54Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Effects of withdrawal of antiparkinson medication on gait and clinical score in the Parkinson patient</title><author><name sortKey="Pederson, S W" sort="Pederson, S W" uniqKey="Pederson S" first="S. W." last="Pederson">S. W. Pederson</name><affiliation><mods:affiliation>Departments of Clinical Neurophysiology and Neurology, Linköping Hospital, Sweden</mods:affiliation></affiliation></author><author><name sortKey="Eriksson, T" sort="Eriksson, T" uniqKey="Eriksson T" first="T." last="Eriksson">T. Eriksson</name><affiliation><mods:affiliation>Departments of Pharmacology, University of Gothenburg, Sweden</mods:affiliation></affiliation></author><author><name sortKey="Oberg, B" sort="Oberg, B" uniqKey="Oberg B" first="B." last="Öberg">B. Öberg</name><affiliation><mods:affiliation>Departments of Clinical Neurophysiology and Neurology, Linköping Hospital, Sweden</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:E8FD9C2A334D90F3AFF97EF49B6BBA0430CA8B54</idno><date when="1991" year="1991">1991</date><idno type="doi">10.1111/j.1600-0404.1991.tb04894.x</idno><idno type="url">https://api.istex.fr/document/E8FD9C2A334D90F3AFF97EF49B6BBA0430CA8B54/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">000364</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Effects of withdrawal of antiparkinson medication on gait and clinical score in the Parkinson patient</title><author><name sortKey="Pederson, S W" sort="Pederson, S W" uniqKey="Pederson S" first="S. W." last="Pederson">S. W. Pederson</name><affiliation><mods:affiliation>Departments of Clinical Neurophysiology and Neurology, Linköping Hospital, Sweden</mods:affiliation></affiliation></author><author><name sortKey="Eriksson, T" sort="Eriksson, T" uniqKey="Eriksson T" first="T." last="Eriksson">T. Eriksson</name><affiliation><mods:affiliation>Departments of Pharmacology, University of Gothenburg, Sweden</mods:affiliation></affiliation></author><author><name sortKey="Oberg, B" sort="Oberg, B" uniqKey="Oberg B" first="B." last="Öberg">B. Öberg</name><affiliation><mods:affiliation>Departments of Clinical Neurophysiology and Neurology, Linköping Hospital, Sweden</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Acta Neurologica Scandinavica</title><idno type="ISSN">0001-6314</idno><idno type="eISSN">1600-0404</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="1991-07">1991-07</date><biblScope unit="volume">84</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="7">7</biblScope><biblScope unit="page" to="13">13</biblScope></imprint><idno type="ISSN">0001-6314</idno></series><idno type="istex">E8FD9C2A334D90F3AFF97EF49B6BBA0430CA8B54</idno><idno type="DOI">10.1111/j.1600-0404.1991.tb04894.x</idno><idno type="ArticleID">ANE7</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0001-6314</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Parkinson's disease</term><term>gait</term><term>measurement</term><term>pharmacological</term><term>therapy</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">ABSTRACT Objective testing of medication is needed in Parkinson's disease. Gait analysis and clinical evaluation were done before and after a 24‐h withdrawal of Parkinson medication. Twelve patients with stable, mild to moderate idiopathic parkinsonism (Hoehn and Yahr 1‐3; seven men and five women mean age 59.9 years, mean duration of disease 6 years) were tested with gait analysis walking in five different paces. Velocity of gait, stride length and stride frequency, as well as stride length at constant velocity were calculated. Regression coefficients for the relation between stride length and stride frequency were also calculated. Clinical scoring according to the Webster rating scale and Hoehn and Yahr were performed for each test. Clinical functional assessment with a specially designed rise and gait test, an arm cycle test and the wooden rods test were done. Evaluated clinical score increased significantly (p < 0.05) using both clinical tests. Maximum gait velocity (p < 0.01), stride length at max. velocity (p < 0.01), and stride length at constant velocity (p < 0.03) were significantly decreased without medication. Stride frequency did not change. In the functional assessment tests only performance on the arm cycle test (p < 0.03) was less well performed without medication. There was correlation between clinical score, gait and clinical functional assessment. The methods used detected significant changes in variables of gait as well as clinical scoring and some of the clinical functional assessments when medication was withdrawn for a 24‐h period. The methods were useful in evaluation of pharmacological treatment.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>S. W. Pederson</name><affiliations><json:string>Departments of Clinical Neurophysiology and Neurology, Linköping Hospital, Sweden</json:string></affiliations></json:item><json:item><name>T. Eriksson</name><affiliations><json:string>Departments of Pharmacology, University of Gothenburg, Sweden</json:string></affiliations></json:item><json:item><name>B. Öberg</name><affiliations><json:string>Departments of Clinical Neurophysiology and Neurology, Linköping Hospital, Sweden</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>gait</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>measurement</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Parkinson's disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>pharmacological</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>therapy</value></json:item></subject><articleId><json:string>ANE7</json:string></articleId><language><json:string>eng</json:string></language><abstract>ABSTRACT Objective testing of medication is needed in Parkinson's disease. Gait analysis and clinical evaluation were done before and after a 24‐h withdrawal of Parkinson medication. Twelve patients with stable, mild to moderate idiopathic parkinsonism (Hoehn and Yahr 1‐3; seven men and five women mean age 59.9 years, mean duration of disease 6 years) were tested with gait analysis walking in five different paces. Velocity of gait, stride length and stride frequency, as well as stride length at constant velocity were calculated. Regression coefficients for the relation between stride length and stride frequency were also calculated. Clinical scoring according to the Webster rating scale and Hoehn and Yahr were performed for each test. Clinical functional assessment with a specially designed rise and gait test, an arm cycle test and the wooden rods test were done. Evaluated clinical score increased significantly (p > 0.05) using both clinical tests. Maximum gait velocity (p > 0.01), stride length at max. velocity (p > 0.01), and stride length at constant velocity (p > 0.03) were significantly decreased without medication. Stride frequency did not change. In the functional assessment tests only performance on the arm cycle test (p > 0.03) was less well performed without medication. There was correlation between clinical score, gait and clinical functional assessment. The methods used detected significant changes in variables of gait as well as clinical scoring and some of the clinical functional assessments when medication was withdrawn for a 24‐h period. The methods were useful in evaluation of pharmacological treatment.</abstract><qualityIndicators><score>7.589</score><pdfVersion>1.5</pdfVersion><pdfPageSize>576 x 792 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>5</keywordCount><abstractCharCount>1647</abstractCharCount><pdfWordCount>3589</pdfWordCount><pdfCharCount>22272</pdfCharCount><pdfPageCount>7</pdfPageCount><abstractWordCount>251</abstractWordCount></qualityIndicators><title>Effects of withdrawal of antiparkinson medication on gait and clinical score in the Parkinson patient</title><genre><json:string>article</json:string></genre><host><volume>84</volume><publisherId><json:string>ANE</json:string></publisherId><pages><total>7</total><last>13</last><first>7</first></pages><issn><json:string>0001-6314</json:string></issn><issue>1</issue><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1600-0404</json:string></eissn><title>Acta Neurologica Scandinavica</title><doi><json:string>10.1111/(ISSN)1600-0404</json:string></doi></host><publicationDate>1991</publicationDate><copyrightDate>1991</copyrightDate><doi><json:string>10.1111/j.1600-0404.1991.tb04894.x</json:string></doi><id>E8FD9C2A334D90F3AFF97EF49B6BBA0430CA8B54</id><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/E8FD9C2A334D90F3AFF97EF49B6BBA0430CA8B54/fulltext/pdf</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/E8FD9C2A334D90F3AFF97EF49B6BBA0430CA8B54/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/E8FD9C2A334D90F3AFF97EF49B6BBA0430CA8B54/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">Effects of withdrawal of antiparkinson medication on gait and clinical score in the Parkinson patient</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><availability><p>WILEY</p></availability><date>1991</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">Effects of withdrawal of antiparkinson medication on gait and clinical score in the Parkinson patient</title><author><persName><forename type="first">S. W.</forename><surname>Pederson</surname></persName><note type="correspondence"><p>Correspondence: Stephen Wørlich Pedersen, Department of Clinical Neurophysiology, University Hospital, S‐58 185 Linköping, Sweden</p></note><affiliation>Departments of Clinical Neurophysiology and Neurology, Linköping Hospital, Sweden</affiliation></author><author><persName><forename type="first">T.</forename><surname>Eriksson</surname></persName><affiliation>Departments of Pharmacology, University of Gothenburg, Sweden</affiliation></author><author><persName><forename type="first">B.</forename><surname>Öberg</surname></persName><affiliation>Departments of Clinical Neurophysiology and Neurology, Linköping Hospital, Sweden</affiliation></author></analytic><monogr><title level="j">Acta Neurologica Scandinavica</title><idno type="pISSN">0001-6314</idno><idno type="eISSN">1600-0404</idno><idno type="DOI">10.1111/(ISSN)1600-0404</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="1991-07"></date><biblScope unit="volume">84</biblScope><biblScope unit="issue">1</biblScope><biblScope unit="page" from="7">7</biblScope><biblScope unit="page" to="13">13</biblScope></imprint></monogr><idno type="istex">E8FD9C2A334D90F3AFF97EF49B6BBA0430CA8B54</idno><idno type="DOI">10.1111/j.1600-0404.1991.tb04894.x</idno><idno type="ArticleID">ANE7</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>1991</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>ABSTRACT Objective testing of medication is needed in Parkinson's disease. Gait analysis and clinical evaluation were done before and after a 24‐h withdrawal of Parkinson medication. Twelve patients with stable, mild to moderate idiopathic parkinsonism (Hoehn and Yahr 1‐3; seven men and five women mean age 59.9 years, mean duration of disease 6 years) were tested with gait analysis walking in five different paces. Velocity of gait, stride length and stride frequency, as well as stride length at constant velocity were calculated. Regression coefficients for the relation between stride length and stride frequency were also calculated. Clinical scoring according to the Webster rating scale and Hoehn and Yahr were performed for each test. Clinical functional assessment with a specially designed rise and gait test, an arm cycle test and the wooden rods test were done. Evaluated clinical score increased significantly (p < 0.05) using both clinical tests. Maximum gait velocity (p < 0.01), stride length at max. velocity (p < 0.01), and stride length at constant velocity (p < 0.03) were significantly decreased without medication. Stride frequency did not change. In the functional assessment tests only performance on the arm cycle test (p < 0.03) was less well performed without medication. There was correlation between clinical score, gait and clinical functional assessment. The methods used detected significant changes in variables of gait as well as clinical scoring and some of the clinical functional assessments when medication was withdrawn for a 24‐h period. The methods were useful in evaluation of pharmacological treatment.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>gait</term></item><item><term>measurement</term></item><item><term>Parkinson's disease</term></item><item><term>pharmacological</term></item><item><term>therapy</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1991-07">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><original>false</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/E8FD9C2A334D90F3AFF97EF49B6BBA0430CA8B54/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Publishing Ltd</publisherName><publisherLoc>Oxford, UK</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)1600-0404</doi><issn type="print">0001-6314</issn><issn type="electronic">1600-0404</issn><idGroup><id type="product" value="ANE"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="ACTA NEUROLOGICA SCANDINAVICA">Acta Neurologica Scandinavica</title></titleGroup></publicationMeta><publicationMeta level="part" position="07001"><doi origin="wiley">10.1111/ane.1991.84.issue-1</doi><numberingGroup><numbering type="journalVolume" number="84">84</numbering><numbering type="journalIssue" number="1">1</numbering></numberingGroup><coverDate startDate="1991-07">July 1991</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="0000700" status="forIssue"><doi origin="wiley">10.1111/j.1600-0404.1991.tb04894.x</doi><idGroup><id type="unit" value="ANE7"></id></idGroup><countGroup><count type="pageTotal" number="7"></count></countGroup><titleGroup><title type="tocHeading1">Original Article</title></titleGroup><copyright>1991 Blackwell Munksgaard</copyright><eventGroup><event type="firstOnline" date="2009-01-29"></event><event type="publishedOnlineFinalForm" date="2009-01-29"></event><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.6 mode:FullText source:HeaderRef result:HeaderRef" date="2010-04-20"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:4.0.1" date="2014-03-15"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-14"></event></eventGroup><numberingGroup><numbering type="pageFirst" number="7">7</numbering><numbering type="pageLast" number="13">13</numbering></numberingGroup><correspondenceTo>Stephen Wørlich Pedersen, Department of Clinical Neurophysiology, University Hospital, S‐58 185 Linköping, Sweden</correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:ANE.ANE7.pdf"></link></linkGroup></publicationMeta><contentMeta><unparsedEditorialHistory>Accepted for publication November 11, 1990</unparsedEditorialHistory><countGroup><count type="referenceTotal" number="15"></count><count type="linksCrossRef" number="4"></count></countGroup><titleGroup><title type="main">Effects of withdrawal of antiparkinson medication on gait and clinical score in the Parkinson patient</title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1" corresponding="yes"><personName><givenNames>S. W.</givenNames><familyName>Pederson</familyName></personName></creator><creator creatorRole="author" xml:id="cr2" affiliationRef="#a2"><personName><givenNames>T.</givenNames><familyName>Eriksson</familyName></personName></creator><creator creatorRole="author" xml:id="cr3" affiliationRef="#a1"><personName><givenNames>B.</givenNames><familyName>Öberg</familyName></personName></creator></creators><affiliationGroup><affiliation xml:id="a1" countryCode="SE"><unparsedAffiliation>Departments of Clinical Neurophysiology and Neurology, Linköping Hospital, Sweden</unparsedAffiliation></affiliation><affiliation xml:id="a2" countryCode="SE"><unparsedAffiliation>Departments of Pharmacology, University of Gothenburg, Sweden</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en"><keyword xml:id="k1">gait</keyword><keyword xml:id="k2">measurement</keyword><keyword xml:id="k3">Parkinson's disease</keyword><keyword xml:id="k4">pharmacological</keyword><keyword xml:id="k5">therapy</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><p><b>ABSTRACT</b> Objective testing of medication is needed in Parkinson's disease. Gait analysis and clinical evaluation were done before and after a 24‐h withdrawal of Parkinson medication. Twelve patients with stable, mild to moderate idiopathic parkinsonism (Hoehn and Yahr 1‐3; seven men and five women mean age 59.9 years, mean duration of disease 6 years) were tested with gait analysis walking in five different paces. Velocity of gait, stride length and stride frequency, as well as stride length at constant velocity were calculated. Regression coefficients for the relation between stride length and stride frequency were also calculated. Clinical scoring according to the Webster rating scale and Hoehn and Yahr were performed for each test. Clinical functional assessment with a specially designed rise and gait test, an arm cycle test and the wooden rods test were done. Evaluated clinical score increased significantly (p < 0.05) using both clinical tests. Maximum gait velocity (p < 0.01), stride length at max. velocity (p < 0.01), and stride length at constant velocity (p < 0.03) were significantly decreased without medication. Stride frequency did not change. In the functional assessment tests only performance on the arm cycle test (p < 0.03) was less well performed without medication. There was correlation between clinical score, gait and clinical functional assessment. The methods used detected significant changes in variables of gait as well as clinical scoring and some of the clinical functional assessments when medication was withdrawn for a 24‐h period. The methods were useful in evaluation of pharmacological treatment.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>Effects of withdrawal of antiparkinson medication on gait and clinical score in the Parkinson patient</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>Effects of withdrawal of antiparkinson medication on gait and clinical score in the Parkinson patient</title></titleInfo><name type="personal"><namePart type="given">S. W.</namePart><namePart type="family">Pederson</namePart><affiliation>Departments of Clinical Neurophysiology and Neurology, Linköping Hospital, Sweden</affiliation><description>Correspondence: Stephen Wørlich Pedersen, Department of Clinical Neurophysiology, University Hospital, S‐58 185 Linköping, Sweden</description><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">T.</namePart><namePart type="family">Eriksson</namePart><affiliation>Departments of Pharmacology, University of Gothenburg, Sweden</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">B.</namePart><namePart type="family">Öberg</namePart><affiliation>Departments of Clinical Neurophysiology and Neurology, Linköping Hospital, Sweden</affiliation><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article"></genre><originInfo><publisher>Blackwell Publishing Ltd</publisher><place><placeTerm type="text">Oxford, UK</placeTerm></place><dateIssued encoding="w3cdtf">1991-07</dateIssued><edition>Accepted for publication November 11, 1990</edition><copyrightDate encoding="w3cdtf">1991</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="references">15</extent></physicalDescription><abstract lang="en">ABSTRACT Objective testing of medication is needed in Parkinson's disease. Gait analysis and clinical evaluation were done before and after a 24‐h withdrawal of Parkinson medication. Twelve patients with stable, mild to moderate idiopathic parkinsonism (Hoehn and Yahr 1‐3; seven men and five women mean age 59.9 years, mean duration of disease 6 years) were tested with gait analysis walking in five different paces. Velocity of gait, stride length and stride frequency, as well as stride length at constant velocity were calculated. Regression coefficients for the relation between stride length and stride frequency were also calculated. Clinical scoring according to the Webster rating scale and Hoehn and Yahr were performed for each test. Clinical functional assessment with a specially designed rise and gait test, an arm cycle test and the wooden rods test were done. Evaluated clinical score increased significantly (p < 0.05) using both clinical tests. Maximum gait velocity (p < 0.01), stride length at max. velocity (p < 0.01), and stride length at constant velocity (p < 0.03) were significantly decreased without medication. Stride frequency did not change. In the functional assessment tests only performance on the arm cycle test (p < 0.03) was less well performed without medication. There was correlation between clinical score, gait and clinical functional assessment. The methods used detected significant changes in variables of gait as well as clinical scoring and some of the clinical functional assessments when medication was withdrawn for a 24‐h period. The methods were useful in evaluation of pharmacological treatment.</abstract><subject lang="en"><genre>Keywords</genre><topic>gait</topic><topic>measurement</topic><topic>Parkinson's disease</topic><topic>pharmacological</topic><topic>therapy</topic></subject><relatedItem type="host"><titleInfo><title>Acta Neurologica Scandinavica</title></titleInfo><genre type="Journal">journal</genre><identifier type="ISSN">0001-6314</identifier><identifier type="eISSN">1600-0404</identifier><identifier type="DOI">10.1111/(ISSN)1600-0404</identifier><identifier type="PublisherID">ANE</identifier><part><date>1991</date><detail type="volume"><caption>vol.</caption><number>84</number></detail><detail type="issue"><caption>no.</caption><number>1</number></detail><extent unit="pages"><start>7</start><end>13</end><total>7</total></extent></part></relatedItem><identifier type="istex">E8FD9C2A334D90F3AFF97EF49B6BBA0430CA8B54</identifier><identifier type="DOI">10.1111/j.1600-0404.1991.tb04894.x</identifier><identifier type="ArticleID">ANE7</identifier><accessCondition type="use and reproduction" contentType="copyright">1991 Blackwell Munksgaard</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Blackwell Publishing Ltd</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000364 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 000364 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Corpus
|type= RBID
|clé= ISTEX:E8FD9C2A334D90F3AFF97EF49B6BBA0430CA8B54
|texte= Effects of withdrawal of antiparkinson medication on gait and clinical score in the Parkinson patient
}}
| This area was generated with Dilib version V0.6.23. |  |